Literature DB >> 31258798

HEART RATE VARIABILITY IN METABOLICALLY HEALTHY AND METABOLICALLY UNHEALTHY OBESE PREMENOPAUSAL WOMEN.

M Rastović1, B Srdić Galić2, O Barak3, E Stokić4, R Vasiljev5.   

Abstract

CONTENT: Metabolically healthy obese (MHO) individuals are characterized by absence of metabolic syndrome. The role of autonomic nervous system in metabolic profile of obese subjects has not been sufficiently investigated.
OBJECTIVE: We analyzed heart rate variability (HRV) in MHO and metabolically unhealthy obese (MUO) premenopausal women.
DESIGN: In 42 women metabolic profile was defined as MHO and MUO. SUBJECTS AND METHODS: For metabolic profile Wildman, IDF and HOMA-IR criteria were used. Autonomic nervous system activity was assessed by analysis of heart rate variability.
RESULTS: There was no significant difference in HRV between MHO and MUO premenopausal women. In Wildman division, after adjustment for systolic blood pressure, RRNN and LF/HF were statistically different between groups (p=0.0001; p=0.029). In IDF division, adjusting for waist circumference, LF was significantly different between groups (p=0.004). In HOMA division, adjusting for HOMA, groups were different in SDNN (p=0.009), RMSSD (p=0.002), pNN50 (p=0.003), HF(p=0.002) and TP (p=0.005).
CONCLUSIONS: Autonomic nervous system does not share the leading role in premenopausal women metabolic profile. The differences in HRV between MHO and MUO women depend on the metabolic health criteria. Systolic blood pressure, HOMA and waist circumference have significant effect on HRV differences between MHO and MUO premenopausal women.

Entities:  

Keywords:  heart rate variability; metabolically healthy obesity; metabolically unhealthy obesity

Year:  2016        PMID: 31258798      PMCID: PMC6586747          DOI: 10.4183/aeb.2016.35

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  30 in total

1.  Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects.

Authors:  S Lindmark; U Wiklund; P Bjerle; J W Eriksson
Journal:  Diabet Med       Date:  2003-05       Impact factor: 4.359

2.  Prolonged (48-hour) modest hyperinsulinemia decreases nocturnal heart rate variability and attenuates the nocturnal decrease in blood pressure in lean, normotensive humans.

Authors:  Maja Petrova; Raymond Townsend; Karen L Teff
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

3.  Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy.

Authors:  V F C Neves; M F Silva de Sá; L Gallo; A M Catai; L E B Martins; J C Crescêncio; N M Perpétuo; E Silva
Journal:  Braz J Med Biol Res       Date:  2007-04       Impact factor: 2.590

4.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.

Authors:  James B Meigs; Peter W F Wilson; Caroline S Fox; Ramachandran S Vasan; David M Nathan; Lisa M Sullivan; Ralph B D'Agostino
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

5.  What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Authors:  M Brochu; A Tchernof; I J Dionne; C K Sites; G H Eltabbakh; E A Sims; E T Poehlman
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

6.  The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.

Authors:  P K Stein; J I Barzilay; P P Domitrovich; P M Chaves; J S Gottdiener; S R Heckbert; R A Kronmal
Journal:  Diabet Med       Date:  2007-04-02       Impact factor: 4.359

7.  Autonomic cardiovascular regulation in obesity.

Authors:  K Laederach-Hofmann; L Mussgay; H Rúddel
Journal:  J Endocrinol       Date:  2000-01       Impact factor: 4.286

8.  Impact of body fat mass extent on cardiac autonomic alterations in women.

Authors:  J Sztajzel; A Golay; V Makoundou; T N O Lehmann; V Barthassat; K Sievert; Z Pataky; F Assimacopoulos-Jeannet; E Bobbioni-Harsch
Journal:  Eur J Clin Invest       Date:  2009-05-26       Impact factor: 4.686

9.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

10.  Obesity and heart rate variability in men with myocardial infarction.

Authors:  Katarzyna Piestrzeniewicz; Katarzyna Łuczak; Małgorzata Lelonek; Jerzy Krzysztof Wranicz; Jan Henryk Goch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

View more
  1 in total

1.  AGING, HEART RATE VARIABILITY AND METABOLIC IMPACT OF OBESITY.

Authors:  Marina Rastović; Biljana Srdić-Galić; Otto Barak; Edita Stokić; Snežana Polovina
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.